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Blood platelets from most species, including man, 
have the ability to take up serotonin (5hydroxytryp 
tamine, 5HT) from the surrounding medium, by two 
different mechanisms: one so-called “active” mecha- 
nism, following a Michaelis-Menten type kinetics, and 
one “passive” mechanism, having the characteristics 
of simple diffusion [l-3]. The active uptake is in- 
hibited noncompetitively by a variety of metabolic 
inhibitors f2,4,5]. Tricyclic antidepressants, pheno- 
thiazines, cocain, and tryptamine have been shown to 
inhibit the uptake competitively [6,7]. 
Studies of SHT uptake in platelets are of interest 
not only with regard to platelet biochemistry and 
transport phenomena in general, but also with regard 
to neurochemistry. It is well established that 5HT 
plays an important role in the central nervous sy* 
tern, probably as a transmitter. Furthermore, the 
mechanisms for uptake and storage of 5HT in neu- 
rones and platelets seem to be analogous, if not iden- 
tical. Since the metabolism of neurones is difficult to 
study, the easily available blood platelets can be re- 
garded as a convenient model with regard to 5HT up 
take and storage. 
The purpose of the present report is to demonstrate 
that the active uptake of 5HT in human blood plate 
lets in vitro requires the presence of sodium as well as 
chloride, and that choline (Ch+), which is generally 
considered to be an inert cation, exerts a competitive 
inhibitory effect on the uptake of 5HT. 
2. Methods 
Blood was drawn from the cubital vein of healthy 
donors and mixed in cellulose nitrate tubes with one 
tenth the volume of EDTA, 1.5%, in 0.5% NaCl. 
Platelet-rich plasma (PRP) was obtained by centrifuga- 
tion (250 X g) for 20 min at room temperature. Ali- 
quots of 1 ml PRP were transferred (with a plast 
pipette) to thin-walled polypropylene tubes, mixed 
with 1 ml cold isotonic saline and centrifuged for 
15 min (2500 X g) at 4”. The supernatant was dis- 
carded, the test tubes allowed to drain, and the 
remaining supematant carefully wiped away. The 
platelet pellet was resuspended (using a “Whirlimixer”, 
Scientific Industries Internat., Inc.) in 2 ml cold in- 
cubation medium, containing phosphate buffer, and 
NaCl, KCl, or choline chloride (ChCl) in varying con- 
centrations. The final medium was isotonic or slightly 
hypertonic (shown not to interfere significantly with 
the rate of 5HT uptake). Incubation with 14C-5HT 
(5-hydroxytryptamine-3- 14C creatinine sulphate from 
The Radiochemical Center, Amersham, specific activity 
adjusted to 10 PC/mole X 10e6, dissolved in lop3 M 
HCl) was carried out for 5 to 8 min in a water shaking 
bath at 37”, after temperature equilibration for 9 min. 
The 5HT was added in a volume not exceeding 25 ~1. 
The incubation was interrupted by transferring the 
test tubes to ice water, and the platelets were isolated 
by centrifugation (2500 X g) for 25 min at 4’. After 
draining, 1 ml of distilled water was added to the 
pellet, and the 5HT was completely released by freez- 
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ing overnight at -20’) followed by thawing and cen- 
trifugation. One half ml of the supernatant was 
mixed with Bray’s solution [8] and the radioactivity 
measured in a Packard Tri-Carb liquid scintillation 
counter. Blank values, to be subtracted from the total 
measured radioactivity, were obtained by adding 
14C-5HT after the test tubes had been transferred to 
ice water, just prior to centrifugation. (“Washing” 
was not found suitable, since it was found to give loss 
of intracellular 5HT). As internal standards were used 
samples to which 14C-SHT was added after the final 
separation. 
The reliability of this method has been calculated 
in duplicate experiments. Standard error (based on 
differences within pairs) were found to be ? 2% of 
pair means. platelets were counted in a phase contrast 
microscope. platelet recovery by resuspension was 
found to be fairly constant at 85%. 
3. Results 
3.1. Sodium dependence 
In one series the platelets were incubated with 
sodium chloride and sodium phosphate buffer at 6 dif- 
ferent pH values, while in a duplicate series sodium was 
replaced by potassium. It is seen from fig. 1 that there 
is no net uptake without Na+ present. The uptake is 
also markedly dependent on pH, which is in accor- 
dance with the findings of Stacey [6]. 
3.2. Chloride dependence and inhibitory effect of 
choline 
Platelets were incubated with sodium and potassium 
phosphate buffer plus increasing amounts of NaCl or 
ChCl. The total osmolality of the medium varied 
from about 0.29 to 0.39 M. It is seen from fig. 2 that 
there is no net uptake without Cl- present. The 5HT 
uptake increases up to a NaCl concentration of about 
5 X lop2 M. With increasing concentrations of ChCl, 
on the other hand, the serotonin uptake levels off at a 
ChCl concentration of about 2 X 10e2 M, whereafter 
it decreases at higher concentrations, and gives a 
maximal 5HT uptake which is only about 50% of that 
obtained with NaCI. Independent experiments have 
shown that the lower uptake with ChCl than with 
NaCl can only partially be explained by a stimulatory 
effect of Na+ (which was already present in near op- 
timal concentration as part of the buffer). Thus, Ch+ 
seemed to have an inhibitory effect on the uptake. 
To study the kinetics of this inhibition, platelets 
Fig. 1. Uptake of 5HT in platelets at varying pH with and with- 
out sodium. Incubation for 8 min at 37’ with 14C-5HT 0.5 
X lo@ M. Incubation medium: Sodium phosphate buffer and 
NaCl, [Na+] = 175 X 10e3 M, [Cl] = 75 X lop3 M (0); potas- 
sium phosphate buffer and KCl, [K+] = 175 X lop3 M, [Cl-] 
= 75 X 1O-3 M (a). Uptake expressed as mole X 1O-g/1Og 
platelets. 
0 
1 
Fig. 2. Uptake of 5HT in platelets at increasing concentrations 
of NaCl or ChCl. Incubation for 8 min at 37’ with 14C-SHT 
0.5 X 1 0m6 M. Incubation medium: Phosphate buffer [ (Na+) 
:(K+) = 4: 11, 0.1 M, pH 7.3, plus NaCl (0); phosphate buffer 
as above plus ChCl (0). Uptake expressed as mole X 10p9/ 
lo9 platelets. 
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were incubated in phosphate buffer with increasing 
concentrations of 14C-SHT at different levels of 
[ChCl] . The chloride concentration and total osmolali- 
ty were kept constant by adding NaCl in proper 
amounts to the different samples. The reciprocal plots 
of the net uptakes (fig. 3) show that the inhibitory 
effect of Ch+ is of a pure competitive type. When the 
slopes are plotted against [Ch+] (insertion in fig. 3) 
the inhibition is thus seen to be linear, with an inhibi- 
tor constant Ki = 2 X low2 M. 
4. Discussion 
Sodium dependence is a property shared by many 
membrane transport mechanisms. Recently it has been 
shown that 5HT uptake by synaptosomes prepared 
from rat brain is also sodiumdependent [9]. Prada 
and collaborators have found that sodium is essential 
I I 
1 2 3 4 5 
l/[5HTjWl=10-6) 
Fig. 3. Main figure: Double reciprocal plot of uptake of 5HT 
at varying concentrations of 14C-5HT, at different [CH+] . In- 
cubation for 5 min at 37O. Incubation media: Phosphate buffer 
[(Na+):(K+) = 4: 11, 0.1 M, pH 7.3, plus ChCl and NaCl. 0, 
[Ch+] 0; n , [Ch+] 1.5 x 1O-2 M; o, [Ch+] A(0 x 1O-2 M; 
a, [Ch+] 6.0 X lo-’ M. NaCl added in cfiplementary 
amounts to final [Cl-] 75 X 1O-3 M. V expressed as mole 
X 10-9/109 platelets. 
Inserted figure: Slopes from main figure plotted against 
[Ch+] . 
for maintaining normal ultrastructure and 5HT binding 
capacity in rabbit blood platelets [lo] , which might 
suggest hat the sodium dependence demonstrated in 
the present study is an unspecific phenomenon. How- 
ever, the present author has found that, within the 
time intervals used in this study, preincubation with- 
out Na+ has little effect on subsequent uptake rates, 
and that the loss of 1‘%5HT from platelets was prac- 
tically unaffected by [Na’] in the medium. Thus 
sodium dependence seems to be a specific property of 
the uptake mechanism per se. Corresponding results 
have been found with regard to chloride [ 111, showing 
that chloride dependence also is a specific property 
of the uptake mechanism. However, chloride can part- 
ly be replaced by some unphysiologic, small diffusible 
anions like Br-, NOT and NO, 
Since the uptake of 5HT is competitively inhibited 
by choline, and choline itself is taken up in certain 
neurones by an active, sodium-dependent process [ 121, 
a common uptake mechanism for 5HT and choline 
must be considered. However, the author has been un- 
able to demonstrate active uptake of 14C-choline 
chloride in human blood platelets [ 111. 
Choline adds to the group of compounds known to 
inhibit competitively the uptake of 5HT in blood plate- 
lets. The fact that the competitive inhibitors have 
widely different chemical structures, suggests that the 
binding of 5HT to a hypothetical carrier in the plasma 
membrane is rather unspecific. In contrast, the storage 
of 5HT within platelets, in the so-called dense osmio 
philic granules [ 131, seems to be dependent on a spe- 
cific mechanism [ 141. 
The inhibition of 5HT uptake by choline is of inte- 
rest in connection with the common use of choline as 
an inert substitute for sodium in experiments on mem- 
brane transport. The possibility that choline may inter- 
fere with the transport mechanism under study has to 
be taken into consideration. 
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